Navigation Links
Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Bavituximab Phase II Breast Cancer Trial
Date:4/29/2008

ing time to tumor progression, duration of response, overall patient survival and safety parameters. Patients may continue to receive bavituximab alone after completion of chemotherapy as long as the cancer does not progress and side effects are acceptable.

Tumor response in this study will be evaluated using Response Evaluation Criteria in Solid Tumors (RECIST) parameters. The trial is being conducted in the Republic of Georgia according to International Conference on Harmonization (ICH) and Good Clinical Practices (GCP) standards.

The National Cancer Institute estimates that approximately 178,480 U.S. women were diagnosed with cancer of the breast in 2007 and about 40,460 women died of the disease. According to the World Health Organization, breast cancer is the most commonly diagnosed cancer in women, and is second only to lung cancer as a leading cause of female cancer deaths.

Bavituximab is a monoclonal antibody that binds to a phospholipid called phosphatidylserine that is usually located inside normal cells, but which becomes exposed on the outside of the cells that line the blood vessels of tumors, creating a specific target for anti-cancer treatments. Bavituximab is believed to help mobilize the body's immune system to destroy the blood vessels needed for tumor growth and spread. In a Phase Ib pilot trial in advanced cancer patients, bavituximab plus chemotherapy appeared to have a safety profile consistent with chemotherapy alone and showed positive signs of clinical activity, achieving objective response or disease stabilization in 50% of the evaluable patients. Peregrine has received regulatory approval to conduct three Phase II trials to study the anti-tumor effects of bavituximab in combination with chemotherapy. These include two breast cancer protocols and a non-small cell lung cancer protocol. Bavituximab is in clinical trials in the U.S. in patients with advanced solid tumors and in patients co-infected with HCV and HIV.

'/>"/>
SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Peregrine Researchers Present New Preclinical Data at AACR Annual Meeting Confirming Unique Anti-Tumor Mechanism of Bavituximab
2. Preclinical Study Presented at AACR Annual Meeting Shows Peregrines Anti-PS Immunocytokines Can Generate Protective Immune Responses in a Highly Aggressive Breast Cancer Model
3. Preclinical Study Presented at AACR Annual Meeting Shows Broad Anti-Cancer Potential of Peregrines anti-PS Vascular Targeting Antibodies
4. Clinical Experience With Peregrines Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents
5. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer
6. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
7. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
8. Peregrine Announces Addition of The Johns Hopkins Hospital as Study Site for Bavituximab Trial in HCV Patients Co-Infected With HIV
9. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
10. Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
11. Peregrine Pharmaceuticals Doses First Patient in Clinical Trial of Bavituximab in HCV Patients Co-Infected With HIV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... TWi Pharmaceuticals, Inc. (4180.TT) today announced that ... States Food and Drug Administration (FDA) on its ... 125mg/ml oral suspension, the generic equivalent to Par ... under Hatch Waxman rules, it will be entitled ... completed the pre-launch preparation of the generic drug.  ...
(Date:8/27/2014)... Columbia and MENLO PARK, Calif. ... Inc. , (OTCQB: DMPI), developer of advanced cancer ... at the 16th Annual Rodman & Renshaw Global Investment ... LLC. The presentation will take place Tuesday, September 9th at ... floor) at the New York Palace Hotel in ...
(Date:8/27/2014)... 27, 2014 Varian Medical Systems (NYSE: VAR) today broke ... Salt Lake City manufacturing facility and allow ... Utah to ultimately create 1,000 new full ... " Utah is home ... of whom can be credited with Varian,s success in the ...
Breaking Medicine Technology:TWi Pharmaceuticals Receives US FDA Final Approval on Generic Megestrol Acetate 125mg/ml Oral Suspension 2DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 2DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 3DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 4Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 3Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 4
... Nfocus Neuromedical, Inc., an innovative medical device company ... brain aneurysms, today announced that the company received U.S. ... Vessel Occlusion System (VOS).  The Acta VOS provides physicians ... an array of common and potentially serious vascular lesions. ...
... 11, 2011 Reportlinker.com announces that a new ... Novo Nordisk A/S: PharmaVitae Profile ... Introduction This analysis ... Nordisk in the prescription pharmaceutical sector. The profile ...
Cached Medicine Technology:Nfocus Neuromedical Announces FDA 510(k) Clearance for Next Generation Device to Treat Vascular Lesions 2Reportlinker Adds Novo Nordisk A/S: PharmaVitae Profile 2
(Date:8/27/2014)... Beach, Florida (PRWEB) August 28, 2014 ... Kevin Harrington, Chairman of As Seen On TV, Inc., ... as “The Millionaire Maker”. as Excelerate attendees will learn ... and will have the ability to pitch to an ... World Renowned Business Experts and Millionaire Mentors directly to ...
(Date:8/27/2014)... 2014 For those who want ... ASP.NET hosting products are very practical. Top10BestSEOHosting.com today ... FatCow are the best ASP.NET hosting suppliers of ... as a top web hosting provider for a ... with it today. Recently proclaimed one of the ...
(Date:8/27/2014)... 28, 2014 Delta, a reliable supplier ... several practical Cat D7R Dozers to its used ... spokesman has announced that all these items are offered ... is to expand Delta’s market share in the coming ... launch the special offer; he has much confidence in ...
(Date:8/27/2014)... 28, 2014 Recently, UWDress.com, a popular ... women, has unveiled its new range of elegant ... in this new assortment. All the company's new and ... to 62 percent off. , This experienced company ... corset bridesmaid dresses, simple bridal gowns, backless party outfits, ...
(Date:8/27/2014)... Charlotte, NC (PRWEB) August 27, 2014 Taking ... extremes, the Steele Creek YMCA will host its ... Race on Saturday, September 13 at YMCA Camp ... in three race divisions: adult, youth and teams. Within ... pushing themselves to their physical limit - for a worthy ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com Releases the Best ASP.NET Hosting Suppliers of This Year: Hostgator, Arvixe and FatCow 2Health News:Reliable Supplier Delta Adds New Items To Its Used Bulldozer Collection 2Health News:Elegant Bridesmaid Dresses For 2014 Now Available At UWDress.com 2Health News:C2 Survival Racers Go to Extremes to Provide Kids with YMCA Programs 2
... ScienceMONTERREY, Mexico, Feb. 17 Join the movement ... Birth Education Conference. The presentations will benefit ... birth practices and advanced methods that will better ... and child. This important conference is for ObGyns, ...
... Global Prevention Network(TM) as AffiliateDALLAS and PARIS, Feb. ... in disease prevention services, has signed an affiliation ... jointly deliver preventive medicine services in Paris, France, ... of Excellence for Prevention Plan members throughout the ...
... Helps Launch Event Honoring Local BoyCHICAGO, Feb. 17 ... Hiatt Foundation along with his wife, Paula, announced the ... February 28, 2009, to be hosted by legendary broadcaster ... fundraising event for the newly created foundation, named after ...
... NuVasive, Inc. (Nasdaq: NUVA ), a medical ... treatments for the spine, announced today that Patrick Williams, Vice ... Musculoskeletal Conference at the University of Nevada in Las ... at 8:20 a.m. PT.A live Web cast of the presentation ...
... professionals believe that they should also participate in injury ... by emergency medicine researchers at the Medical College of ... the only health care providers who see people in ... likely to identify safety or health issues ...
... In the blink of an eye, people at risk ... diseases such as diabetic retinopathy and age-related macular degeneration. ... of Energy,s Oak Ridge National Laboratory to understand semiconductor ... digital cameras that take pictures of the retina. Those ...
Cached Medicine News:Health News:International Humanization of Birth Conference 2Health News:U.S. Preventive Medicine(R), American Hospital of Paris Sign Affiliation Agreement to Deliver Preventive Medicine Services 2Health News:U.S. Preventive Medicine(R), American Hospital of Paris Sign Affiliation Agreement to Deliver Preventive Medicine Services 3Health News:Bill Kurtis to Host First 'Art of Living Gala' on February 28, 2009 2Health News:Bill Kurtis to Host First 'Art of Living Gala' on February 28, 2009 3Health News:NuVasive to Present at Canaccord Adams Musculoskeletal Conference 2Health News:NuVasive to Present at Canaccord Adams Musculoskeletal Conference 3Health News:Emergency medical professionals support their participation in prevention programs 2Health News:ORNL, UT project could save vision of millions 2Health News:ORNL, UT project could save vision of millions 3
Each handle is designed to fit a specific trephine size....
... German Craftsmanship have produced ... in the world. Ocutek ... to you! Only holders ... certificate, which requires and ...
Permits rotation of the globe during examination. Overall length,123mm....
... of German Craftsmanship have ... instrumentation in the world. ... available to you! Only ... Meisterbrief certificate, which requires ...
Medicine Products: